You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 115 No. 9, September 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS PRESENTED AT THE ANNUAL MEETING OF THE SOUTHERN CALIFORNIA CHAPTER OF THE AMERICAN COLLEGE OF SURGEONS, RANCHO MIRAGE, CALIF, JAN 20, 1980
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (26)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Serum Gastrin and Human Chorionic Gonadotropin in the Zollinger-Ellison Syndrome

Bruce E. Stabile, MD; Glenn D. Braunstein, MD; Edward Passaro, Jr, MD

Arch Surg. 1980;115(9):1090-1095.


Abstract

• Prior to total gastrectomy, serum levels of gastrin and human chorionic gonadotropin (HCG) and its alpha- and beta-subunits ({alpha}-HCG and β-HCG) were determined by radioimmunoassays in 40 patients with the Zollinger-Ellison syndrome. Basal serum gastrin levels greater than 1,500 pg/mL were found only in patients with metastases to lymph nodes or liver, while levels greater than 8,000 indicated massive liver replacement by tumor. Gastrin levels less than 1,500 pg/mL had no correlation with malignant behavior. Neither the calcium-infusion nor secretin-injection test was useful in identifying tumors as benign or malignant. Basal serum levels of {alpha}-HCG were elevated (> 7 ng/mL) in four of 20 patients with metastatic gastrinoma and were normal in all 16 patients with benign disease. There was a significant correlation between basal gastrin and {alpha}-HCG levels in patients with malignant gastrinoma but not for those with benign tumors. The results suggest that serum gastrin and {alpha}-HCG levels can be useful in assessing the biologic behavior of gastrinomas and in planning appropriate surgical and nonsurgical treatment.

(Arch Surg 115:1090-1095, 1980)



Author Affiliations

From the General Surgery Service, Veterans Administration Wadsworth Medical Center (Drs Stabile and Passaro); the Departments of Surgery (Drs Stabile and Passaro) and Medicine (Dr Braunstein), UCLA School of Medicine; and the Endocrinology Section, Department of Medicine, Cedars-Sinai Medical Center (Dr Braunstein), Los Angeles.


Footnotes

Accepted for publication May 7, 1980.

Read before the annual meeting of the Southern California Chapter of the American College of Surgeons, Rancho Mirage, Calif, Jan 19, 1980.

Reprint requests to Surgical Service (691/112K3), VA Wadsworth Medical Center, Wilshire and Sawtelle Blvd, Los Angeles, CA 90073 (Dr Stabile).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Overexpression of Epidermal Growth Factor and Hepatocyte Growth Factor Receptors in a Proportion of Gastrinomas Correlates with Aggressive Growth and Lower Curability
Peghini et al.
Clin. Cancer Res. 2002;8:2273-2285.
ABSTRACT | FULL TEXT  

Prospective Study of the Clinical Course, Prognostic Factors, Causes of Death, and Survival in Patients With Long-Standing Zollinger-Ellison Syndrome
Yu et al.
JCO 1999;17:615-615.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.